Knowledge of, and Access to Narcan (Naloxone) among Nebraskan Adults: in 2020, 2021, and 2022
In this research report RDAR faculty added a series of questions to the Nebraska Annual Social Indicators Survey (NASIS) to assess how many Nebraskans knew what Narcan and naloxone are, if they knew where to obtain it, and if they knew how to use Narcan. We also asked these same questions in 2021 and in 2022. This report highlights the results of this research.
Methamphetamine-Involved Overdose Deaths, Use Estimates & Treatment Utilization in Nebraska: Integrating the Most Recent Surveillance Data to Understand the Epidemiology of Methamphetamine Use in Nebraska
This research uses publicly accessible datasets to examine how methamphetamine-related health outcomes have recently varied in Nebraska and jointly discusses these data to assess the evolving impact of methamphetamine use on the health of Nebraskans.
Analysis of Nebraskan Admissions to Publicly Funded Substance Treatment Centers in 2017 by Core-Based Statistical Areas
This report utilizes Treatment Episode Data Set (TEDS) which tracks both admissions and discharges from substance use treatment facilities in the United States of America. RDAR researchers use the TEDS data to look at differences in substances reported at admission in Nebraska between Metropolitan core-based statistical areas (CBSA) counties, Micropolitan CBSA counties, and counties that are Outside CBSA areas.
Changes in Substance Use Among Nebraskans and the Local Region from 2008-2009 to 2017-2018
This research utilizes national mental health and substance abuse survey reports summarizing recent findings regarding trends in prevalence for a variety of public health indicators. RDAR researchers utilized this comparison analysis to examine trends in mental health and substance use in Nebraska, comparing Nebraska prevalence estimates to regional and national trends over the past decade.